Abstract
The ROMICAT-II trial shows that CT coronary angiography is safe and fast for the exclusion of clinically significant obstructive coronary artery disease in low-risk patients with acute chest pain. Several issues and questions relating to the low prevalence of disease and the actual benefit to patients remain to be answered.
| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 615-616 |
| Number of pages | 2 |
| Journal | Nature Reviews Cardiology |
| Volume | 9 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2012 |
Research programs
- EMC NIHES-03-30-01